Creative Planning Eli Lilly & CO Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Eli Lilly & CO stock. As of the latest transaction made, Creative Planning holds 228,526 shares of LLY stock, worth $182 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

228,526

Previous 228,675 0.07%

Holding current value

$182 Million

Previous $207 Million 2.21%

% of portfolio

0.2%

Previous 0.22%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$772.14 - $960.02 $115,048 - $143,042	-149 Reduced 0.07%	228,526 $202 Million
Q2 2024 Aug 15, 2024	BUY	$724.87 - $909.04 $6.53 Million - $8.19 Million	9,007 Added 4.1%	228,675 $207 Million
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $29.6 Million - $39.6 Million	50,013 Added 29.48%	219,668 $171 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $4.1 Million - $4.83 Million	7,806 Added 4.82%	169,655 $98.9 Million
Q3 2023 Nov 16, 2023	BUY	$434.7 - $599.3 $5.22 Million - $7.2 Million	12,011 Added 8.02%	161,849 $86.9 Million
Q2 2023 Jul 21, 2023	SELL	$350.74 - $468.98 $1.05 Million - $1.4 Million	-2,989 Reduced 1.96%	149,838 $70.3 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $1.55 Million - $1.81 Million	-4,974 Reduced 3.15%	152,827 $52.5 Million
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $3.24 Million - $3.77 Million	10,068 Added 6.81%	157,801 $57.7 Million
Q3 2022 Nov 03, 2022	SELL	$296.48 - $337.87 $342,434 - $390,239	-1,155 Reduced 0.78%	147,733 $47.8 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $6.86 Million - $8.06 Million	24,622 Added 19.81%	148,888 $48.3 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $150,670 - $187,245	642 Added 0.52%	124,266 $35.6 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $1.53 Million - $1.9 Million	-6,822 Reduced 5.23%	123,624 $34.1 Million
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $2.51 Million - $3.09 Million	11,318 Added 9.5%	130,446 $30.1 Million
Q2 2021 Aug 04, 2021	SELL	$180.55 - $233.54 $45.1 Million - $58.3 Million	-249,590 Reduced 67.69%	119,128 $27.3 Million
Q1 2021 Apr 30, 2021	SELL	$164.32 - $212.72 $578,242 - $748,561	-3,519 Reduced 0.95%	368,718 $68.9 Million
Q4 2020 Jan 29, 2021	BUY	$130.46 - $172.63 $3.02 Million - $3.99 Million	23,132 Added 6.63%	372,237 $62.8 Million
Q3 2020 Nov 05, 2020	BUY	$146.22 - $169.13 $729,637 - $843,958	4,990 Added 1.45%	349,105 $51.7 Million
Q2 2020 Jul 23, 2020	BUY	$136.42 - $164.18 $428,222 - $515,361	3,139 Added 0.92%	344,115 $56.5 Million
Q1 2020 May 05, 2020	SELL	$119.05 - $147.35 $10.9 Million - $13.5 Million	-91,787 Reduced 21.21%	340,976 $47.3 Million
Q4 2019 Jan 30, 2020	SELL	$106.92 - $132.43 $4.4 Million - $5.44 Million	-41,106 Reduced 8.67%	432,763 $56.9 Million
Q3 2019 Nov 01, 2019	SELL	$106.79 - $116.16 $2.38 Million - $2.59 Million	-22,278 Reduced 4.49%	473,869 $53 Million
Q2 2019 Jul 26, 2019	BUY	$110.79 - $129.32 $6,425 - $7,500	58 Added 0.01%	496,147 $55 Million
Q1 2019 Apr 24, 2019	BUY	$111.31 - $131.02 $116,318 - $136,915	1,045 Added 0.21%	496,089 $64.4 Million
Q4 2018 Feb 01, 2019	BUY	$105.9 - $118.64 $395,112 - $442,645	3,731 Added 0.76%	495,044 $57.3 Million
Q3 2018 Oct 25, 2018	SELL	$85.86 - $107.31 $6.21 Million - $7.76 Million	-72,300 Reduced 12.83%	491,313 $52.7 Million
Q2 2018 Jul 20, 2018	BUY	$75.7 - $86.88 $337,243 - $387,050	4,455 Added 0.8%	563,613 $48.1 Million
Q1 2018 Apr 18, 2018	BUY	$74.21 - $87.6 $48,088 - $56,764	648 Added 0.12%	559,158 $43.3 Million
Q4 2017 Jan 17, 2018	BUY	$81.94 - $87.89 $11,553 - $12,392	141 Added 0.03%	558,510 $47.2 Million
Q3 2017 Oct 17, 2017	BUY	$77.07 - $85.54 $43 Million - $47.8 Million	558,369	558,369 $47.8 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Eli Lilly & CO Transaction History